Regeneron Pharmaceuticals (REGN) Q1 2026 Earnings

Jan 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
8.22
9.78
11.33
12.89

Details

Expected EPS
10.735553
Actual EPS
11.44
Surprise EPS
0.7
Surprise Percent
+6.56%

Description

⁨Regeneron Pharmaceuticals⁩ (⁦REGN⁩) has reported earnings of ⁦11.44⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts